Immunovia publ AB
Research Immunovia publ AB (IMMNOV) on Bullrun: market cap SEK 127.81M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerIMMNOV
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryDiagnostics & Research
- CurrencySEK
- Market capSEK 127.81M
- Financial periodFY2023
- RevenueSEK 1.80M
- Revenue growth49.7%
- Net income-SEK 309.44M
- Free cash flow-SEK 147.06M
Valuation Snapshot
latest market cap is SEK 127.81M.
About Immunovia publ AB
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual. Immunovia AB (publ) was incorporated in 2007 and is headquartered in Lund, Sweden.
Frequently asked questions
What is Immunovia publ AB's market cap?
Immunovia publ AB's market capitalization is SEK 127.81M.
What does Immunovia publ AB do?
Immunovia AB (publ), a diagnostic company, develops and validates blood test for detecting pancreatic cancer in Sweden. It also focuses on the development and commercialization of blood-based testing to detect proteins and antibodies that indicate pancreatic cancer in an individual.